Local News Aptevo Therapeutics Announces APVO436 Monotherapy Is Active in Patients Who Have Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Aptevo Therapeutics | August 18, 2021 Aptevo Therapeutics Inc., a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on…dcorriganAugust 18, 2021 Read More
Local News HDT Bio Announces Agreement with Korea’s Quratis to Co-Develop Innovative COVID-19 Vaccine in Asia HDT Bio Corporation | August 17, 2021 HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced today an…dcorriganAugust 17, 2021 Read More
Local News Just – Evotec Biologics Opens J.POD® 1 US in Redmond, Washington Life Science Washington | August 17, 2021 Evotec SE announced the opening of the company’s late-stage clinical and commercial biologics cGMP manufacturing…dcorriganAugust 17, 2021 Read More
Local News GentiBio Nets $157 Million to Restore Immune Tolerance with Tregs BioSpace | August 16, 2021 GentiBio is developing engineered regulatory T cells (Tregs) to build a better immune system and…dcorriganAugust 16, 2021 Read More
Local News Researchers Pinpoint ‘Correlates of Protection’ for Moderna Vaccine Fred Hutch | August 13, 2021 In the race to develop new and better vaccines and boosters to block COVID-19, scientists…dcorriganAugust 13, 2021 Read More
Local News Curebase, Adaptive Biotechnologies Announce Collaboration to Expand Clinical Study Access PR NewsWire | August 12, 2021 Curebase, a company committed to democratizing access to clinical studies, and Adaptive Biotechnologies Corp. (Nasdaq: ADPT),…dcorriganAugust 12, 2021 Read More
Local News Eliem Is Latest Seattle-Area Biotech to Go Public, Raises $80M to Help Fuel Treatments for Nervous System Disorders GeekWire | August 11, 2021 Eliem Therapeutics joined the ranks of publicly traded companies from Washington state, pricing 6.4 million shares…dcorriganAugust 11, 2021 Read More
Local News Kineta Announces Patent Issuance for U.S. Patent Covering Composition of Matter of KCP506, a Novel Non-Opioid Therapy for Chronic Pain BioSpace | August 11, 2021 Kineta Inc, through its subsidiary Kineta Chronic Pain LLC, announced today that the company has…dcorriganAugust 11, 2021 Read More
Local News Seeking to Expand Targeted Therapy for Lung Cancer Fred Hutch | August 11, 2021 Targeted therapies have transformed outcomes for lung cancer patients. After reduced smoking rates, drugs that…dcorriganAugust 11, 2021 Read More
Local News Seagen and RemeGen Announce Exclusive Worldwide License and Co-Development Agreement for Disitamab Vedotin Seagen, Inc. | August 10, 2021 Seagen Inc., a world leader and pioneer in antibody-drug conjugate (ADC) therapies, and RemeGen Co.,…dcorriganAugust 10, 2021 Read More